Antibody test post-vaccination not needed, says Niti Aayog's V K Paul

In the medium to long term, it is a "cell-mediated" immune response of the vaccine that is more critical and requires sophisticated systems of testing, Paul said

Covid vaccination, vaccine, coronavirus vaccine
A medic administers the dose of vaccine to a beneficiary, at Moti Lal Nehru Medical College vaccination in Prayagraj
Business Standard New Delhi
1 min read Last Updated : May 28 2021 | 12:44 AM IST
People need not take an antibody test after the vaccination since it is only one measure of immunity, V K Paul, member-health, Niti Aayog said. In the medium to long term, it is a “cell-mediated” immune response of the vaccine that is more critical and requires sophisticated systems of testing, he added.

Paul was responding to the concerns of people who have not shown antibody presence after taking two doses of the vaccine. He said trials were on to find whether a booster dose of Covaxin is needed after the first two doses. “As and when we find that a booster dose is required in relation to any vac­cine, it will be told,” Paul said.


He also said antibodies decline with time and may vary from person to person based on their previous exposure as well. “As a public health measure, we are all increasing our protection. 

We as a community will be protected through vaccination,” Paul said.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus VaccineVaccination

Next Story